glp 1 gip dual agonist weight loss and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Machine Learning Designs Potent Dual

All statistical analyses were performed using SPSS (version: 24.0

Symptoms Tiredness Pallor Reduced ability to combat infection Being breathless Weakness Listless Tingling of the hands and feet Bleeding gums Issues with menstrual cycle Sore, lower eyelids (lining) Pale in appearance Irregular heartbeat or palpitations Bruising that appears without reason Smooth tongue Hair loss Folic acid (necessary for DNA synthesis) can also be responsible for causing anaemia

Second, not all AIG diagnoses translate to PA

Clinical manifestations may involve multiple systems, including neurological, gastrointestinal, and musculoskeletal domains

ALK and ROS1)

Effect on FDA Peptide Policy Robert F